UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):     April 29, 2004

 

 

SANGAMO BIOSCIENCES, INC.

(Exact name of Registrant as specified in its charter)

 

 

 

 

ITEM 7.		EXHIBITS
	(c)	Exhibits
			99.1	Press Release of Sangamo BioSciences, Inc. dated April 29, 2004 reporting Sangamo BioSciences, Inc.’s financial results for the quarter ended March 31, 2004.
ITEM 12.		RESULTS OF OPERATIONS AND FINANCIAL CONDITION

 

The information in this Item 12 is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section.  The information in this Item 12 shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.

 

On April 29, 2004, Sangamo BioSciences, Inc. issued a press release announcing its financial results for the quarter ended March 31, 2004.  A copy of the press release is attached as Exhibit 99.1.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

DATE:  April 29, 2004

 

				SANGAMO BIOSCIENCES, INC.
			By:	/s/ EDWARD O. LANPHIER II
				Edward O. Lanphier II
				President, Chief Executive Officer

 

2

 

Exhibit Index

 

 

3